TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF

TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF

The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ER-CC1-XPF inhibition, therefore improving the therapeutic benefit of i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WEST, Frederick, WEILBEER, Claudia, TUSZYNSKI, Jack, WEINFELD, Michael, GENTILE, Francesco, KARIMI-BUSHERI, Feridoun, ELMENOUFY, Ahmed H, BARAKAT, Khaled Hassan
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WEST, Frederick
WEILBEER, Claudia
TUSZYNSKI, Jack
WEINFELD, Michael
GENTILE, Francesco
KARIMI-BUSHERI, Feridoun
ELMENOUFY, Ahmed H
BARAKAT, Khaled Hassan
description The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ER-CC1-XPF inhibition, therefore improving the therapeutic benefit of irradiation or other cancer treatment, or reducing the dosage and adverse effects associated with such treatment.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022306603A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022306603A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022306603A13</originalsourceid><addsrcrecordid>eNrjZLAPcQxydw3x9HNXcPFzVAhyDXD0DFLw9FMICfX1D1JwdvXxCVYI83QECnl4OnmGePr7Kfi7KbgGOTsb6kYEuPEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDIyNjAzMzA2NHQ2PiVAEA-FAq0Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF</title><source>esp@cenet</source><creator>WEST, Frederick ; WEILBEER, Claudia ; TUSZYNSKI, Jack ; WEINFELD, Michael ; GENTILE, Francesco ; KARIMI-BUSHERI, Feridoun ; ELMENOUFY, Ahmed H ; BARAKAT, Khaled Hassan</creator><creatorcontrib>WEST, Frederick ; WEILBEER, Claudia ; TUSZYNSKI, Jack ; WEINFELD, Michael ; GENTILE, Francesco ; KARIMI-BUSHERI, Feridoun ; ELMENOUFY, Ahmed H ; BARAKAT, Khaled Hassan</creatorcontrib><description>The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ER-CC1-XPF inhibition, therefore improving the therapeutic benefit of irradiation or other cancer treatment, or reducing the dosage and adverse effects associated with such treatment.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=US&amp;NR=2022306603A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=US&amp;NR=2022306603A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEST, Frederick</creatorcontrib><creatorcontrib>WEILBEER, Claudia</creatorcontrib><creatorcontrib>TUSZYNSKI, Jack</creatorcontrib><creatorcontrib>WEINFELD, Michael</creatorcontrib><creatorcontrib>GENTILE, Francesco</creatorcontrib><creatorcontrib>KARIMI-BUSHERI, Feridoun</creatorcontrib><creatorcontrib>ELMENOUFY, Ahmed H</creatorcontrib><creatorcontrib>BARAKAT, Khaled Hassan</creatorcontrib><title>TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF</title><description>The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ER-CC1-XPF inhibition, therefore improving the therapeutic benefit of irradiation or other cancer treatment, or reducing the dosage and adverse effects associated with such treatment.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPcQxydw3x9HNXcPFzVAhyDXD0DFLw9FMICfX1D1JwdvXxCVYI83QECnl4OnmGePr7Kfi7KbgGOTsb6kYEuPEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDIyNjAzMzA2NHQ2PiVAEA-FAq0Q</recordid><startdate>20220929</startdate><enddate>20220929</enddate><creator>WEST, Frederick</creator><creator>WEILBEER, Claudia</creator><creator>TUSZYNSKI, Jack</creator><creator>WEINFELD, Michael</creator><creator>GENTILE, Francesco</creator><creator>KARIMI-BUSHERI, Feridoun</creator><creator>ELMENOUFY, Ahmed H</creator><creator>BARAKAT, Khaled Hassan</creator><scope>EVB</scope></search><sort><creationdate>20220929</creationdate><title>TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF</title><author>WEST, Frederick ; WEILBEER, Claudia ; TUSZYNSKI, Jack ; WEINFELD, Michael ; GENTILE, Francesco ; KARIMI-BUSHERI, Feridoun ; ELMENOUFY, Ahmed H ; BARAKAT, Khaled Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022306603A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WEST, Frederick</creatorcontrib><creatorcontrib>WEILBEER, Claudia</creatorcontrib><creatorcontrib>TUSZYNSKI, Jack</creatorcontrib><creatorcontrib>WEINFELD, Michael</creatorcontrib><creatorcontrib>GENTILE, Francesco</creatorcontrib><creatorcontrib>KARIMI-BUSHERI, Feridoun</creatorcontrib><creatorcontrib>ELMENOUFY, Ahmed H</creatorcontrib><creatorcontrib>BARAKAT, Khaled Hassan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEST, Frederick</au><au>WEILBEER, Claudia</au><au>TUSZYNSKI, Jack</au><au>WEINFELD, Michael</au><au>GENTILE, Francesco</au><au>KARIMI-BUSHERI, Feridoun</au><au>ELMENOUFY, Ahmed H</au><au>BARAKAT, Khaled Hassan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF</title><date>2022-09-29</date><risdate>2022</risdate><abstract>The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ER-CC1-XPF inhibition, therefore improving the therapeutic benefit of irradiation or other cancer treatment, or reducing the dosage and adverse effects associated with such treatment.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2022306603A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEST,%20Frederick&rft.date=2022-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022306603A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true